Delivery Order SPE2DR25D3301-SPE2DR26F19HP
Award Date 12/10/25
Potential Completion Date 12/11/25
Potential Value $54K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 18, 2025, for Zepbound 7.5 mg/0.5 mL pen injections with a ceiling value of $1,134.73. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with ultimate completion scheduled for November 19, 2025. The order will be fulfilled at AmerisourceBergen's Conshohocken facility...
- The Defense Logistics Agency awarded a delivery order valued at $45,186.89 to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections. This is a firm fixed price delivery order with an ultimate completion date of December 23, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on December 3, 2025, for the supply of Zepbound 10 mg/0.5 ml pen injections with a ceiling value of $3,623.56. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 4, 2025. The contract is performed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 22, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections. This firm fixed-price delivery order, valued at $21,693.46, represents a non-competitive set-aside procurement and is scheduled for completion by October 23, 2025. The award will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a $27,388.63 delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This firm fixed-price, non-set-aside contract is scheduled for completion by December 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $38,628.48 delivery order contract by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 27, 2025. This award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's broader relationship...
- AmerisourceBergen Drug Corp was awarded a $1,107.42 firm fixed price delivery order on December 3, 2025, by the Defense Logistics Agency (DLA) for Zepbound 12.5 mg/0.5 ml pen injections. This is a non-set-aside competitive award with an ultimate completion date of December 4, 2025 and place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,804.63 by the Defense Logistics Agency on December 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. The contract employs firm fixed-price pricing with no set-aside designation, indicating a competitive award process. The award is scheduled for completion by December 19, 2025, with performance taking place at the vendor's Conshohocken facility. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,525.20 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 ml pen injections on July 24, 2025. This firm fixed-price, competitively awarded contract is classified as a delivery order with no set-aside designation and carries an ultimate completion date of July 25, 2025. The pharmaceutical product will be performed from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $12,150.18 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on November 17, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of November 18, 2025. The pharmaceutical product will be delivered to the contracting location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...